APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalamine

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Selected research

Market Structure

Global Mesalamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025199 pages

Choose your research edition.

Industry ResearchMesalamine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalamine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Mesalamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalamine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalamine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.

In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.

Read the full market overview

This report provides an overview of the global Mesalamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesalamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesalamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesalamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesalamine Segment by Company

Syntese A/S

Divis Laboratories

Cambrex Corporation

Ipca Laboratories

Hangzhou Brother

PharmaZell

Lianyungang Fengheng Biopharm

Lasa Loboratory

Erregierre SpA

Corden Pharma Bergamo

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Mesalamine Segment by Type

Purity ≥ 97%

Purity ≥ 98%

Purity ≥ 99%

Mesalamine Segment by Application

Mesalazine Tablets

Mesalazine Capsules

Others

Mesalamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mesalamine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mesalamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mesalamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mesalamine Industry Trends Table 2. Mesalamine Industry Drivers Table 3. Mesalamine Industry Opportunities and Challenges Table 4. Mesalamine Industry Restraints Table 5. Global Mesalamine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mesalamine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mesalamine Sales by Manufacturers (MT) & (2021-2026) Table 8. Global Mesalamine Sales Market Share by Manufacturers Table 9. Global Mesalamine Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Mesalamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mesalamine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mesalamine Manufacturers, Product Type & Application Table 13. Global Mesalamine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mesalamine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity ≥ 97% Table 17. Major Manufacturers of Purity ≥ 98% Table 18. Major Manufacturers of Purity ≥ 99% Table 19. Global Mesalamine Sales by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global Mesalamine Sales by Type (2021-2026) & (MT) Table 21. Global Mesalamine Sales by Type (2027-2032) & (MT) Table 22. Global Mesalamine Sales Market Share by Type (2021-2026) Table 23. Global Mesalamine Sales Market Share by Type (2027-2032) Table 24. Global Mesalamine Revenue by Type 2021 VS 2025 VS 2032 (MT) Table 25. Global Mesalamine Revenue by Type (2021-2026) & (MT) Table 26. Global Mesalamine Revenue by Type (2027-2032) & (MT) Table 27. Global Mesalamine Revenue Market Share by Type (2021-2026) Table 28. Global Mesalamine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Mesalazine Tablets Table 30. Major Manufacturers of Mesalazine Capsules Table 31. Major Manufacturers of Others Table 32. Global Mesalamine Sales by Application 2021 VS 2025 VS 2032 (MT) Table 33. Global Mesalamine Sales by Application (2021-2026) & (MT) Table 34. Global Mesalamine Sales by Application (2027-2032) & (MT) Table 35. Global Mesalamine Sales Market Share by Application (2021-2026) Table 36. Global Mesalamine Sales Market Share by Application (2027-2032) Table 37. Global Mesalamine Revenue by Application 2021 VS 2025 VS 2032 (MT) Table 38. Global Mesalamine Revenue by Application (2021-2026) & (MT) Table 39. Global Mesalamine Revenue by Application (2027-2032) & (MT) Table 40. Global Mesalamine Revenue Market Share by Application (2021-2026) Table 41. Global Mesalamine Revenue Market Share by Application (2027-2032) Table 42. Global Mesalamine Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 43. Global Mesalamine Sales by Region (2021-2026) & (MT) Table 44. Global Mesalamine Sales Market Share by Region (2021-2026) Table 45. Global Mesalamine Sales Forecasted by Region (2027-2032) & (MT) Table 46. Global Mesalamine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Mesalamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 48. North America Mesalamine Sales by Country (2021-2026) & (MT) Table 49. North America Mesalamine Sales by Country (2027-2032) & (MT) Table 50. Europe Mesalamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 51. Europe Mesalamine Sales by Country (2021-2026) & (MT) Table 52. Europe Mesalamine Sales by Country (2027-2032) & (MT) Table 53. Asia Pacific Mesalamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 54. Asia Pacific Mesalamine Sales by Country (2021-2026) & (MT) Table 55. Asia Pacific Mesalamine Sales by Country (2027-2032) & (MT) Table 56. South America, Middle East and Africa Mesalamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 57. South America, Middle East and Africa Mesalamine Sales by Country (2021-2026) & (MT) Table 58. South America, Middle East and Africa Mesalamine Sales by Country (2027-2032) & (MT) Table 59. Global Mesalamine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Mesalamine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Mesalamine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Mesalamine Revenue Market Share by Region (2021-2026) Table 63. Global Mesalamine Revenue Market Share by Region (2027-2032) Table 64. Syntese A/S Company Information Table 65. Syntese A/S Business Overview Table 66. Syntese A/S Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Syntese A/S Mesalamine Product Portfolio Table 68. Syntese A/S Recent Development Table 69. Divis Laboratories Company Information Table 70. Divis Laboratories Business Overview Table 71. Divis Laboratories Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Divis Laboratories Mesalamine Product Portfolio Table 73. Divis Laboratories Recent Development Table 74. Cambrex Corporation Company Information Table 75. Cambrex Corporation Business Overview Table 76. Cambrex Corporation Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cambrex Corporation Mesalamine Product Portfolio Table 78. Cambrex Corporation Recent Development Table 79. Ipca Laboratories Company Information Table 80. Ipca Laboratories Business Overview Table 81. Ipca Laboratories Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ipca Laboratories Mesalamine Product Portfolio Table 83. Ipca Laboratories Recent Development Table 84. Hangzhou Brother Company Information Table 85. Hangzhou Brother Business Overview Table 86. Hangzhou Brother Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Hangzhou Brother Mesalamine Product Portfolio Table 88. Hangzhou Brother Recent Development Table 89. PharmaZell Company Information Table 90. PharmaZell Business Overview Table 91. PharmaZell Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. PharmaZell Mesalamine Product Portfolio Table 93. PharmaZell Recent Development Table 94. Lianyungang Fengheng Biopharm Company Information Table 95. Lianyungang Fengheng Biopharm Business Overview Table 96. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Lianyungang Fengheng Biopharm Mesalamine Product Portfolio Table 98. Lianyungang Fengheng Biopharm Recent Development Table 99. Lasa Loboratory Company Information Table 100. Lasa Loboratory Business Overview Table 101. Lasa Loboratory Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Lasa Loboratory Mesalamine Product Portfolio Table 103. Lasa Loboratory Recent Development Table 104. Erregierre SpA Company Information Table 105. Erregierre SpA Business Overview Table 106. Erregierre SpA Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Erregierre SpA Mesalamine Product Portfolio Table 108. Erregierre SpA Recent Development Table 109. Corden Pharma Bergamo Company Information Table 110. Corden Pharma Bergamo Business Overview Table 111. Corden Pharma Bergamo Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Corden Pharma Bergamo Mesalamine Product Portfolio Table 113. Corden Pharma Bergamo Recent Development Table 114. CTX Lifescience Company Information Table 115. CTX Lifescience Business Overview Table 116. CTX Lifescience Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. CTX Lifescience Mesalamine Product Portfolio Table 118. CTX Lifescience Recent Development Table 119. Ishita Active Pharma Ingredients Company Information Table 120. Ishita Active Pharma Ingredients Business Overview Table 121. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Ishita Active Pharma Ingredients Mesalamine Product Portfolio Table 123. Ishita Active Pharma Ingredients Recent Development Table 124. YC Biotech (Jiangsu) Company Information Table 125. YC Biotech (Jiangsu) Business Overview Table 126. YC Biotech (Jiangsu) Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. YC Biotech (Jiangsu) Mesalamine Product Portfolio Table 128. YC Biotech (Jiangsu) Recent Development Table 129. Xinxiang Tianfeng Fine Chemical Company Information Table 130. Xinxiang Tianfeng Fine Chemical Business Overview Table 131. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio Table 133. Xinxiang Tianfeng Fine Chemical Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Mesalamine Distributors List Table 137. Mesalamine Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Mesalamine Product Image Figure 2. Global Mesalamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesalamine Sales (2021-2032) & (MT) Figure 5. Global Mesalamine Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Mesalamine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity ≥ 97% Image Figure 9. Purity ≥ 98% Image Figure 10. Purity ≥ 99% Image Figure 11. Global Mesalamine Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Mesalamine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Mesalamine Sales Market Share by Type (2021-2032) Figure 14. Global Mesalamine Revenue by Type (2021 VS 2025 VS 2032) & (MT) Figure 15. Global Mesalamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Mesalamine Revenue Market Share by Type (2021-2032) Figure 17. Mesalazine Tablets Image Figure 18. Mesalazine Capsules Image Figure 19. Others Image Figure 20. Global Mesalamine Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 21. Global Mesalamine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Mesalamine Sales Market Share by Application (2021-2032) Figure 23. Global Mesalamine Revenue by Application (2021 VS 2025 VS 2032) & (MT) Figure 24. Global Mesalamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Mesalamine Revenue Market Share by Application (2021-2032) Figure 26. North America Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 27. North America Mesalamine Sales Market Share by Country (2021-2032) Figure 28. U.S. Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 29. Canada Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 30. Mexico Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 31. Europe Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 32. Europe Mesalamine Sales Market Share by Country (2021-2032) Figure 33. Germany Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 34. France Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 35. U.K. Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 36. Italy Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 37. Netherlands Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 38. Asia Pacific Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 39. Asia Pacific Mesalamine Sales Market Share by Country (2021-2032) Figure 40. China Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 41. Japan Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 42. South Korea Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 43. Southeast Asia Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 44. India Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 45. Australia Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 46. South America, Middle East and Africa Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 47. South America, Middle East and Africa Mesalamine Sales Market Share by Country (2021-2032) Figure 48. Brazil Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 49. South Africa Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 50. Saudi Arabia Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 51. Turkey Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 52. Argentina Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 53. UAE Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 54. Egypt Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 55. Chile Mesalamine Sales and Growth Rate (2021-2032) & (MT) Figure 56. Global Mesalamine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Mesalamine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Mesalamine Revenue (2021-2032) & (US$ Million) Figure 59. North America Mesalamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Mesalamine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Mesalamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Mesalamine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Mesalamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Mesalamine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Mesalamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Mesalamine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Mesalamine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 97%
  • Purity ≥ 98%
  • Purity ≥ 99%
Applications
  • Mesalazine Tablets
  • Mesalazine Capsules
  • Others
Companies covered
  • Syntese A/S
  • Divis Laboratories
  • Cambrex Corporation
  • Ipca Laboratories
  • Hangzhou Brother
  • PharmaZell
  • Lianyungang Fengheng Biopharm
  • Lasa Loboratory
  • Erregierre SpA
  • Corden Pharma Bergamo
  • CTX Lifescience
  • Ishita Active Pharma Ingredients
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mesalamine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mesalamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mesalamine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mesalamine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mesalamine Market Dynamics
  1. 2.1 Mesalamine Industry Trends
  2. 2.2 Mesalamine Industry Drivers
  3. 2.3 Mesalamine Industry Opportunities and Challenges
  4. 2.4 Mesalamine Industry Restraints
3 Mesalamine Market by Manufacturers
  1. 3.1 Global Mesalamine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mesalamine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mesalamine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mesalamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesalamine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mesalamine Manufacturers, Product Type & Application
  7. 3.7 Global Mesalamine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesalamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesalamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mesalamine Tier 1, Tier 2, and Tier 3
4 Mesalamine Market by Type
  1. 4.1 Mesalamine Type Introduction
  2. 4.1.1 Purity ≥ 97%
  3. 4.1.2 Purity ≥ 98%
  4. 4.1.3 Purity ≥ 99%
  5. 4.2 Global Mesalamine Sales by Type
  6. 4.2.1 Global Mesalamine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mesalamine Sales by Type (2021-2032)
  8. 4.2.3 Global Mesalamine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Mesalamine Revenue by Type
  10. 4.3.1 Global Mesalamine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Mesalamine Revenue by Type (2021-2032)
  12. 4.3.3 Global Mesalamine Revenue Market Share by Type (2021-2032)
5 Mesalamine Market by Application
  1. 5.1 Mesalamine Application Introduction
  2. 5.1.1 Mesalazine Tablets
  3. 5.1.2 Mesalazine Capsules
  4. 5.1.3 Others
  5. 5.2 Global Mesalamine Sales by Application
  6. 5.2.1 Global Mesalamine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mesalamine Sales by Application (2021-2032)
  8. 5.2.3 Global Mesalamine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Mesalamine Revenue by Application
  10. 5.3.1 Global Mesalamine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mesalamine Revenue by Application (2021-2032)
  12. 5.3.3 Global Mesalamine Revenue Market Share by Application (2021-2032)
6 Global Mesalamine Sales by Region
  1. 6.1 Global Mesalamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mesalamine Sales by Region (2021-2032)
  3. 6.2.1 Global Mesalamine Sales by Region (2021-2026)
  4. 6.2.2 Global Mesalamine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mesalamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mesalamine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mesalamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mesalamine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mesalamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mesalamine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mesalamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mesalamine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mesalamine Revenue by Region
  1. 7.1 Global Mesalamine Revenue by Region
  2. 7.1.1 Global Mesalamine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mesalamine Revenue by Region (2021-2026)
  4. 7.1.3 Global Mesalamine Revenue by Region (2027-2032)
  5. 7.1.4 Global Mesalamine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mesalamine Revenue (2021-2032)
  8. 7.2.2 North America Mesalamine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mesalamine Revenue (2021-2032)
  11. 7.3.2 Europe Mesalamine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mesalamine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mesalamine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mesalamine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mesalamine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Syntese A/S
  2. 8.1.1 Syntese A/S Company Information
  3. 8.1.2 Syntese A/S Business Overview
  4. 8.1.3 Syntese A/S Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Syntese A/S Mesalamine Product Portfolio
  6. 8.1.5 Syntese A/S Recent Developments
  7. 8.2 Divis Laboratories
  8. 8.2.1 Divis Laboratories Company Information
  9. 8.2.2 Divis Laboratories Business Overview
  10. 8.2.3 Divis Laboratories Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Divis Laboratories Mesalamine Product Portfolio
  12. 8.2.5 Divis Laboratories Recent Developments
  13. 8.3 Cambrex Corporation
  14. 8.3.1 Cambrex Corporation Company Information
  15. 8.3.2 Cambrex Corporation Business Overview
  16. 8.3.3 Cambrex Corporation Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cambrex Corporation Mesalamine Product Portfolio
  18. 8.3.5 Cambrex Corporation Recent Developments
  19. 8.4 Ipca Laboratories
  20. 8.4.1 Ipca Laboratories Company Information
  21. 8.4.2 Ipca Laboratories Business Overview
  22. 8.4.3 Ipca Laboratories Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ipca Laboratories Mesalamine Product Portfolio
  24. 8.4.5 Ipca Laboratories Recent Developments
  25. 8.5 Hangzhou Brother
  26. 8.5.1 Hangzhou Brother Company Information
  27. 8.5.2 Hangzhou Brother Business Overview
  28. 8.5.3 Hangzhou Brother Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hangzhou Brother Mesalamine Product Portfolio
  30. 8.5.5 Hangzhou Brother Recent Developments
  31. 8.6 PharmaZell
  32. 8.6.1 PharmaZell Company Information
  33. 8.6.2 PharmaZell Business Overview
  34. 8.6.3 PharmaZell Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PharmaZell Mesalamine Product Portfolio
  36. 8.6.5 PharmaZell Recent Developments
  37. 8.7 Lianyungang Fengheng Biopharm
  38. 8.7.1 Lianyungang Fengheng Biopharm Company Information
  39. 8.7.2 Lianyungang Fengheng Biopharm Business Overview
  40. 8.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lianyungang Fengheng Biopharm Mesalamine Product Portfolio
  42. 8.7.5 Lianyungang Fengheng Biopharm Recent Developments
  43. 8.8 Lasa Loboratory
  44. 8.8.1 Lasa Loboratory Company Information
  45. 8.8.2 Lasa Loboratory Business Overview
  46. 8.8.3 Lasa Loboratory Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lasa Loboratory Mesalamine Product Portfolio
  48. 8.8.5 Lasa Loboratory Recent Developments
  49. 8.9 Erregierre SpA
  50. 8.9.1 Erregierre SpA Company Information
  51. 8.9.2 Erregierre SpA Business Overview
  52. 8.9.3 Erregierre SpA Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Erregierre SpA Mesalamine Product Portfolio
  54. 8.9.5 Erregierre SpA Recent Developments
  55. 8.10 Corden Pharma Bergamo
  56. 8.10.1 Corden Pharma Bergamo Company Information
  57. 8.10.2 Corden Pharma Bergamo Business Overview
  58. 8.10.3 Corden Pharma Bergamo Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Corden Pharma Bergamo Mesalamine Product Portfolio
  60. 8.10.5 Corden Pharma Bergamo Recent Developments
  61. 8.11 CTX Lifescience
  62. 8.11.1 CTX Lifescience Company Information
  63. 8.11.2 CTX Lifescience Business Overview
  64. 8.11.3 CTX Lifescience Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CTX Lifescience Mesalamine Product Portfolio
  66. 8.11.5 CTX Lifescience Recent Developments
  67. 8.12 Ishita Active Pharma Ingredients
  68. 8.12.1 Ishita Active Pharma Ingredients Company Information
  69. 8.12.2 Ishita Active Pharma Ingredients Business Overview
  70. 8.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ishita Active Pharma Ingredients Mesalamine Product Portfolio
  72. 8.12.5 Ishita Active Pharma Ingredients Recent Developments
  73. 8.13 YC Biotech (Jiangsu)
  74. 8.13.1 YC Biotech (Jiangsu) Company Information
  75. 8.13.2 YC Biotech (Jiangsu) Business Overview
  76. 8.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 YC Biotech (Jiangsu) Mesalamine Product Portfolio
  78. 8.13.5 YC Biotech (Jiangsu) Recent Developments
  79. 8.14 Xinxiang Tianfeng Fine Chemical
  80. 8.14.1 Xinxiang Tianfeng Fine Chemical Company Information
  81. 8.14.2 Xinxiang Tianfeng Fine Chemical Business Overview
  82. 8.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio
  84. 8.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mesalamine Value Chain Analysis
  2. 9.1.1 Mesalamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mesalamine Production Mode & Process
  6. 9.2 Mesalamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mesalamine Distributors
  9. 9.2.3 Mesalamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst